MARKET

APVO

APVO

Aptevo Therapeutics Inc
NASDAQ
0.7051
+0.0251
+3.69%
Opening 15:19 04/26 EDT
OPEN
0.6875
PREV CLOSE
0.6800
HIGH
0.7200
LOW
0.6800
VOLUME
157.38K
TURNOVER
0
52 WEEK HIGH
91.96
52 WEEK LOW
0.6700
MARKET CAP
1.13M
P/E (TTM)
-0.0113
1D
5D
1M
3M
1Y
5Y
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
NASDAQ · 2d ago
Weekly Report: what happened at APVO last week (0415-0419)?
Weekly Report · 4d ago
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
NASDAQ · 04/16 16:47
Weekly Report: what happened at APVO last week (0408-0412)?
Weekly Report · 04/15 10:14
Nasdaq Jumps 250 Points; Crude Oil Down 1%
U.S. Stocks traded higher toward the end of trading on Thursday. The Nasdaq Composite surged more than 250 points. The Dow traded up 0.18% while the NASDAQ rose 1.63%. Information technology shares rose by 2.2% and energy shares fell by 0.3%. Constellation Brands reported better-than-expected fourth-quarter earnings.
Benzinga · 04/11 19:21
Why Aptevo Therapeutics Stock Is Cratering
Aptevo Therapeutics Inc. Shares are dropping on heavy trading volume after the company priced its $4.6 million public offering. The company's shares are trading lower on heavy volume. The stock is trading below its 200-day moving average and trend line. Technical analysis can be used to help predict a stock's future price trajectory.
Benzinga · 04/11 19:06
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Fastenal shares dipped 6.7% to $69.73 on Thursday. The company reported worse-than-expected first-quarter financial results. Rallybio Corporation shares climbed 89.6% after company announced a collaboration with Johnson & Johnson. Rent the Runway, Inc. Shares jumped 74.5% after the company reported mixed fourth-quarter results.
Benzinga · 04/11 17:33
NKTR, VERU and EGIO among mid-day movers
U.S. Economy NKTR, VERU and EGIO among mid-day movers. Rent the Runway (RENT) and Rallybio Corp are among the gainers. Aptevo Therapeutics (NA) is one of the biggest losers.
Seeking Alpha · 04/11 16:55
More
About APVO
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, are developed using its ADAPTIR modular protein technology platform. Its preclinical candidate APVO442 is developed using its ADAPTIR-FLEX modular protein technology platform. APVO436 is a bispecific ADAPTIR that is designed to engage CD3 and CD123 to redirect T-cells to destroy leukemia cells expressing the target CD123 molecule on their surface. ALG.APV-527 is a novel investigational bispecific ADAPTIR candidate. APVO603 is a preclinical dual agonist bispecific ADAPTIR candidate designed to simultaneously target 4-1BB (CD137) and OX40 (CD134), both members of the TNF-receptor family.

Webull offers Aptevo Therapeutics Inc stock information, including NASDAQ: APVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APVO stock methods without spending real money on the virtual paper trading platform.